About this episode
Episode Summary: The Cardiometabolic Revolution of Semaglutide, Tirzepatide, and BeyondThis episode provides a comprehensive, evidence-based update on GLP-1 receptor agonists (anti-obesity medications), featuring Dr. Jordan Feigenbaum, Dr. Austin Baraki, and Dr. Spencer Nadolsky. The hosts review the rapid evolution of these drugs—from short-acting injectables to potent multi-agonists like Tirzepatide (Mounjaro/Zepbound) and Retatrutide—which now achieve weight loss efficacy rivaling bariatric surgery.The discussion clarifies the broad, weight-independent benefits these drugs offer for cardiovascular, renal, and liver health (CKM Syndrome). The experts address common concerns, including the high incidence of gastrointestinal side effects and the heavily debated risk of muscle mass loss, concluding the risk is often overblown and easily mitigated by resistance training and adequate protein intake. Finally, they discuss the biggest hurdle to access: cost, and the role of newer oral and compounded options in the evolving landscape.⏱️ Episode Timestamps00:00 Welcome and Introductions00:05:48 Defining GLP-1 and the Incretin Effect00:08:06 Debunking "Nature's Ozempic" (DPP-4 resistance)00:11:17 Evolution of GLP-1 Drugs (Longer duration, higher potency)00:14:35 Defining and Discussing "Food Noise"00:19:43 Semaglutide Efficacy (STEP & SUSTAIN Trials)00:22:36 Tirzepatide Efficacy (SURMOUNT Trials)00:24:50 Triple Agonist Pipeline (Retatrutide)00:28:04 Oral Options and Future Accessibility (Orforglipron)00:33:10 Weight-Independent Cardio Benefits (SELECT Trial)00:38:12 Benefits for Kidney and Liver Health (CKM Syndrome)00:41:47 Emerging Benefits (Sleep Apnea, Addiction, Cancer)00:48:20 Common Side Effects (Nausea, Constipation, Fatigue)00:52:59 Rare/Serious Risks (Pancreatitis, NAION)00:58:36 Muscle Mass Loss Concern (Hype vs. Data)01:13:44 Biggest Hurdle: Cost and Prior Authorization01:16:50 Compounded Versions vs. Research Chemicals01:19:57 Role of Older Anti-Obesity Medications and Microdosing01:24:41 Final Summary🔗 Resources and Next StepsWork with Experts on Cardiometabolic Health:Connect with Dr. Austin Baraki and Dr. Spencer Nadolsky: https://joinvineyard.com/ For evidence-based resistance training programs: barbellmedicine.com/training-programsFor individualized medical and training consultation:
